Abstract: Mineralization procedures for blood and urine suitable for the determination of arsenic by Hydride Generation Atomic Absorption Spectrometry (HGAAS) are studied on model samples, and the results are utilized in biological monitoring investigations. The objective of this work is to obtain good total As recoveries for both matrices regardless of added As species (As(III), As(V), DMA, MMA, AsB, or AsC). Prior to the HGAAS analyses, preparation procedures were controlled under optimised conditions by graphite furnace atomic absorption spectrometry (GFAAS). Two preparation procedures for urine give As recoveries close to 100 % by HGAAS: a) dry ashing at 420¸C with Mg(NO 3 ) 2 on a hot plate, and b) microwave oven decomposition with (NH 4 ) 2 S 2 O 8 . For blood samples, As recoveries by HGAAS range between 95 and 108% for all species when using dry ashing after a pretreatment of samples with HNO 3 and H 2 O 2 in a microwave oven. Wet digestion with (NH 4 ) 2 S 2 O 8 in a microwave oven gives recoveries very near 100% for As inorg: and MMA. For other As species in spiked blood samples, recoveries of less than 20% As are found. Precision and detection limits obtained by both techniques are evaluated as well. For arsenic concentrations of 20 · g dm ¡3 or more in blood and urine, a chemical modi er is recommended for GFAAS analysis; it may or may not be proceeded by a mineralization step. For low As levels encountered in the unexposed population, the HGAAS technique provides reliable results only if a very complete mineralization procedure is used.
Introduction
The \System of Monitoring the Environmental Impact on Population Health", a largescale project in the Czech Republic, has been launched by the Ministry of Health [1] . The aim of this long-term project is to evaluate exposure of the population and establish guidelines for environmental protection and national health policy. The section concerning the biological monitoring (Project V/1) investigates trace element levels of As, Cd, Cu, Hg, Pb and Zn in whole blood, urine, serum, and hair. Ensuring the quality of the results is an inseparable part of the project. However, interlaboratory test comparisons show large di®erences in arsenic levels in blood and urine when obtained at the di®erent participating laboratories. Some discrepancies can be explained by the use of di®erent equipment at the individual laboratories, but more important attention needs to be paid to the validation of the methods and the accuracy of the results.
Ensuring the quality of arsenic determinations in body°uids is a di±cult task, because commercially available certi¯ed reference materials usually do not mention di®erent forms of arsenic. There is only one reference available: CRM No. 18 human urine (NIES, Japan), with certi¯ed values for two arsenic compounds -arsenobetaine and dimethylarsinic acid. Unfortunately, the reference does not cover all arsenic compouds in our study as well as possible arsenic species present in a blood matrix.
In order to discover the reason for the disparate results (most results obtained were low) in participating laboratories, the present study is focused on sample preparation as the most important step to ensure the accuracy of arsenic analyses, especially if di®erent As species are included and hydride generation atomic absorption spectrometry (HGAAS) is used for measurements.
The determination of inorganic arsenic and its metabolites in urine is often used as a convenient and valid estimate of a possible arsenic exposure. After the intake of toxic inorganic arsenic compounds, however, the element is methylated \in vivo" and then excreted as methylated compounds with dimethylarsinic acid (DMA) and monomethylarsonic acid (MMA) being the major metabolites found in urine [2] , [3] . Exposure to MMA and DMA can also be due to their use as selective herbicides [4] . The concentration of arsenic in blood and urine is in°uenced by both dietary intake and respiration, when arsenic compounds penetrate via inhalation of aerosols and pass through lungs to other organs. In foods, arsenic is found mainly in sea products, where arsenobetaine (AsB) and arsenocholine (AsC) are the most frequently reported compounds [5] , [6] . Arsenobetaine, AsB, and arsenocholine, AsC, are both believed to be non-toxic forms because they are not metabolized [6] , although doubts have been raised concerning the biosynthesis of toxic intermediates in humans. In urine, they are found within 1{2 days after eating seafoods [7] , [8] . The elimination of inorganic As and its metabolites is relatively slow, requiring about 4{5 days. In blood, levels of all As forms decrease within a few hours, and therefore blood can be used as a monitor of recent arsenic exposure [9] , [10] .
If arsenic levels are determined by graphite furnace atomic absorption spectrometry (GFAAS), analytical problems associated with the volatility of its compounds are gen-erally suppressed by the use of suitable chemical modi¯ers [2{5] . Mixed palladium and magnesium nitrates are found to be superior to others, especially if chlorides are present in the sample matrix [11] , [12] . This is precisely the case for both matrices studied in this work. Measurements of arsenic by GFAAS may be then performed directly on raw samples without any mineralization step. If the more sensitive HGAAS is applied, however, di®erent responses for individual As forms are observed. In this case, a very complete mineralization is required to quantitatively transform all As species present to the unique As(V) form [12] and to determine either the total As levels or the levels of individual As species if previously separated.
In the framework of this study, the behaviour of arsenic compounds in urine and blood matrices is compared in relation to mineralization step suitable for HGAAS measurements. The e±ciency of procedures and recoveries were controlled by GFAAS measurements using palladium, palladium/magnesium nitrate, and palladium/persulfate modiers. The work was carried out in two di®erent laboratories with di®erent equipment and background corrections. Neutron activation analysis (NAA) was selected as the reference method in order to determine the concentrations of all prepared As compounds and reference material (RM) dilutions [13] .
The proposed methods are useful for routine laboratory analysis and are easily combined with procedures for other analytes prescribed by the monitoring programme.
Experimental

Instrumentation
Results were obtained using atomic absorption systems: a Perkin-Elmer 4000 spectrometer with an HGA-500 (longitudinally heated graphite furnace) and a D 2 background corrector, a Perkin Elmer 4100 ZL spectrometer with a THGA (transversely heated graphite furnace) and Zeeman background correction, a Perkin-Elmer 3300 spectrometer with an FIAS 400 (all Norwalk, USA), and a Unicam 939 AA Solaar spectrometer equipped with a VP-90 hydride system and a Gilson 221 autosampler (Cambridge, UK). For all As measurements graphite tubes with inserted platforms, EDL (Perkin-Elmer) and HCL (Unicam) arsenic lamps, were used throughout. Experimental conditions for the arsenic determination by GFAAS are given in Tables 1 and 2. For the mineralization studies, microwave ovens Milestone MEGA 1200 (Milano, Italy) or Plazmatronika (Warsaw, Poland), or a hot plate SH 4 Jencons with a glass-ceramic heating surface (Bedfordshire, UK), were used.
Reagents
All reagents were of analytical-reagent grade or higher purity. The water used to prepare samples and standards was distilled and further puri¯ed with a Milli-Q system (Millipore, Bedford, USA) or with a Nanopure System (Barnstead, Boston, USA) to a resistivity of 18.2 M cm ¡1 . A quartz apparatus (Acidest, Heraeus, FRG) was used for the distillation of high-purity nitric and hydrochloric acids. Stock solutions of arsenic compounds with concentrations exactly determined by NAA (Nuclear Physics Institute of the Czech Academy of Sciences) were prepared from commercially available salts: sodium arsenite and sodium arsenate (Merck, Germany), disodium hydrogen arsenite (Fluka, Switzerland), dimethylarsinic acid-sodium (Sigma, Germany), or prepared in laboratories of the Department of Organic Chemistry at the Charles University of Prague (arsenobetaine bromide, arsenocholine bromide, monomethyl arsonic acid{sodium salt) according to the prescription [14] . Sodium tetrahydroborate (NaBH 4 ) solutions (1% and 0.2% (m/v) in 0.1% (m/v) NaOH), 10% and 5% (m/v) ascorbic acid, 10% and 5% (m/v) KI, 30% hydrogen peroxide, ammonium peroxosulfate (Merck) prepared in 3% (m/v) NaOH, and magnesium nitrate (Merck, Fluka, Sigma) were also used. Because a suitable standard reference material (RM) with certi¯ed values of all interested arsenic forms was not available, experiments were carried out using urine and blood RMs (Seronorm, Norway, and Bio-Rad, USA) spiked with di®erent As compounds. After evaporation of the liquid, the temperature was gradually increased up to 420ºC and held at 420 o C for 1 hour. After cooling, the residues were dissolved in HCl for HGAAS measurements of low arsenic levels, or in HNO 3 for GFAAS measurements. Thē nal sample volumes were 10 cm 3 .
Blood samples (500 · l) were mixed with 2 cm 3 of 65 vol.% HNO 3 and 150 · l of 30 % H 2 O 2 and digested for 10 minuets in a microwave oven (Plazmatronika) at the maximum power. Then Mg(NO 3 ) 2 was added, and the blood samples were treated on the hot plate in the same way as the urine samples. The¯nal sample volume was 10 cm 3 .
2.3.2 Digestion in a microwave oven after the addition of (NH 4 ) 2 S 2 O 8 .
Urine samples (2 cm 3 ) were mixed with 6 cm
(m/v) NaOH and digested in a microwave oven (Milestone) using an optimised program: 250W (2min.), 0 W (2min.), 400W (6min.), 500W (5min.), 600W (5min.). The resulting samples were diluted to 10 cm 3 with deionized water.
Blood samples (500· l) with 2 cm 3 of conc. HNO 3 and 150 · l of 30 % H 2 O 2 were pretreated in a microwave oven (Milestone) using the following program: 250W (2 min.), 400W (6 min.). The liquid was evaporated on the hot plate at 150ºC, and after cooling, 6 cm 3 of 2% (m/v) (NH 4 ) 2 S 2 O 8 in 3% (m/v) NaOH were added. The vessels were closed, and the same microwave program was applied as for the urine samples.
HGAAS analysis
After mineralization, samples were acidi¯ed with HCl, and the reducing agents, KI and ascorbic acid, were added prior to hydride generation. Reduction was continued over night.
For the FIAS system (Perkin-Elmer) { A reducing agent solution of 1 ml of 5% KI and 5% ascorbic acid was added. The next day HGAAS was performed with the carrier HCl (1+3) and a solution of 0,2% NaBH 4 in 0,1% NaOH was used. Atomization was done in a quartz cell at 900ºC.
For the VP-90 system (Unicam) { A reducing agent solution of 1 ml of 10% KI and 10% ascorbic acid was added, and the carrier was 10% HCl; the reducing solution was 1% NaBH 4 in 0,1% NaOH, which was prepared daily. The quartz tube was heated at 900ºC. Experimental parameters were optimized.
Results and discussion
In our previous work [15] , [16] we con¯rmed that using GFAAS with the appropriate Pd or Pd/Mg modi¯ers, total As concentrations may be e±ciently determined regardless of the species originally present in the sample. The As compounds studied (As(III), As(V), MMA, DMA, AsB, AsC) yielded the identical recoveries of near 100% for both urine and blood matrices after dilution. Thus, GFAAS can be used to verify mineralization procedures of As compounds.
In this work, two mineralization procedures were compared in order to obtain accurate procedures for the HGAAS determination of the total As, regardless of the initial As species present in urine and blood samples. One procedure is based on dry ashing with magnesium nitrate, and the second is based on microwave-assisted decomposition with the addition of ammonium persulfate. Dry ashing methods described earlier using Mg(NO 3 ) 2 as an ashing aid [2] , [17] , [18] were modi¯ed and simpli¯ed to shorten whole process of the sample preparation to less than 2 hours. In addition, the presence of Mg(NO 3 ) 2 in samples is advantageous for GFAAS measurements, because if combined with palladium, it is often used as an universal modi¯er [12] .
Urine Seronorm, lot 403125, (recommended value for total As is 100 · g. dm ¡3 ) was used as a reference sample after dilution to an initial As concentration of 25 · g.dm {3 . Additional As-species were added in concentrations of 25 · g.dm ¡3 of each.
Good recoveries were obtained in the range of 97{103% with relative standard deviations (RSD) (n=5) in the range of 1.2 -5.3% for GFAAS determinations after mineralization with Mg(NO 3 ) 2 . Similar satisfactory results were obtained for the HGAAS analyses, where recoveries ranged between 98 and 103% with RSDs (n=5) in the range of 2.9{5.3%. Analyzed solutions were diluted 10 fold. The limit of detection (LOD) (3s) for the HGAAS determinations as calculated from 10 blank values is 0.2 · g dm ¡3 of each
As compound in the diluted samples. The LOD given by GFAAS measurements after sample mineralization and external calibration is 2 · g dm ¡3 in the diluted solutions.
Since closed systems of sample preparations are usually preferable due to the risk of contamination, speci¯cally at service laboratories, the microwave oven (MO) mineralization of urine with potassium persulfate (5% w/v) prepared in sodium hydroxide was investigated as described for the FI-MO-HGAAS con¯guration [6] . When we applied these agents for the graphite furnace analysis, however, it was di±cult to compensate for a strong background generated during atomization, even when Zeeman background correction was utilized. Concentrations of potassium persulfate in the range of 2{5% were also examined but again resulted in little success with respect to background correction. To avoid such shortcomings, we changed to ammonium persulfate as an alternative mineralization agent. Ammonium persulfate was found to be as powerful an agent as the initially utilized potassium persulfate. Even at a concentration of 2% (w/v) prepared in 3 % (w/v) NaOH, (NH 4 ) 2 S 4 O 8 provides satisfactory results as determined by GFAAS and HGAAS measurements of both pure As species and spiked urine samples. Moreover, background interferences for the GFAAS analysis mentioned above were eliminated. It is believed that during ashing step, a new e®ective Pd-S 2 O 8 modi¯er is formed, similar to that one prepared from K 2 S 2 O 8 as described by Nixon et al. [11] .
The e±ciency of the mineralization of the As species was tested using the control sample for urine (Bio-Rad 60901, 51.8 · g dm ¡3 recommended value for As) digested with (NH 4 ) 2 S 2 O 8 in an MO. The control was spiked with an As species at a concentration of 50 · g dm ¡3 of each (1+1). Recoveries were found in the range between 94 and 101% with RSDs (n = 4{8) in the range of 2.6{4.8 % and between 94 and 106% with RSDs in the range of 3.3{7.0 % for GFAAS and HGAAS determinations, respectively. For HGAAS measurements, solutions were diluted by a factor of 10. The determination of arsenic concentrations in blood samples is not required as frequently as urine, but the comparison of both matrices is important, especially if blood samples are analyzed when monitoring for other analytes. Both of the aforementioned mineralization procedures were simply applied to the blood matrix.
The possibility of direct As determinations in blood by GFAAS without a mineralization step was tested on the spiked control blood sample, Seronorm 404107 (As conc. < LOD). Samples were diluted with 0.1% Triton X-100 and a Pd matrix modi¯er was added to the graphite tube. In a preliminary interference study, it was found that a dilution factor greater than 10 allows for measurement against an external calibration standard prepared from pure standards. For lower dilution factors the standard addition method must be employed.
The dry ashing procedure with Mg(NO 3 ) 2 was veri¯ed using GFAAS measurements with deuterium background correction. For that purpose, Mg(NO 3 ) 2 was added to the calibration sample. On the other hand, Zeeman GFAAS was used to verify the miner-alization procedure in an MO with (NH 4 ) 2 S 2 O 8 . Measurements were performed with a calibration standard modi¯ed with (NH 4 ) 2 S 2 O 8 in NaOH. The decomposition processes were also tested on the spiked blood sample, Seronorm 404107, and the recoveries were evaluated. As can be seen in Table 3 , recoveries of all As species by GFAAS analysis are near 100%, hence we can conclude that no loss occurs during both mineralization procedures, and the method is useful to control this step of the sample preparation. The LOD for the GFAAS measurements with Zeeman background correction is 3 · g dm ¡3 of
As in the diluted solutions. Mineralized samples were diluted 10 fold for HGAAS measurements. The results prove that only the dry ashing procedure with Mg(NO 3 ) 2 ensures an e±cient mineralization and recovery for all As compounds in the blood samples. Since blood samples foam in the presence of Mg(NO 3 ) 2 at higher temperatures, a digestion pretreatment step in the MO using HNO 3 and H 2 O 2 was tested and employed.
On the other hand, the organic species DMA, AsB and AsC in blood were insu±ciently decomposed in the MO when treated with (NH 4 ) 2 S 2 O 8 . The As recoveries obtained were less than 20% (see Table 4 ).
The present study shows that di®erent As species in a given matrix have di®ering resistance to the oxidizing agents used in mineralization processes even in spiked samples. Digestion with (NH 4 ) 2 S 2 O 8 in pressurized PTFE vessels using microwave heating was found to be an e±cient alternative for urine samples, but not for blood samples using HGAAS analysis. In this case, more experiments are required to optimize the procedure. The proposed dry ashing method with Mg(NO 3 ) 2 seems to be the most e®ective procedure for both matrices containing the most common As-containing species.
For the purpose of biological monitoring investigations, our recommended analytical procedures with respect to other elements being analyzed in the given matrices were provided to participating laboratories. Interlaboratory comparisons signi¯cantly improved.
Normal concentrations of arsenic in urine are typically less than 10 · g/g of creatinine. Higher concentrations (up to 100 · g /g of creatinine) are often found among people consuming seafoods. Since dietary evidence of investigated populations is rare, the total As content in urine was completed by the toxicologically relevant arsenic forms (As(III), As(V), MMA, DMA), in order to be sure about nontoxic As exposure. For that purpose, the method suggested by Guo et al. [19] , using L-cysteine reducing agent and HGAAS without any mineralization step, was optimized. Accuracy was veri¯ed by participating in the External Quality Control programme 23, 24 (Erlangen 2000, FRG) . Unfortunately, the L-cysteine method is impossible to use on a blood matrix, as clogging of FIAS capillaries occurs. 
